Rhythm Pharmaceuticals Inc (RYTM) Insider Trading
- $22,046,700.00
- $46,700,907.58
- Sept. 17, 2024
- Todd Foley
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 17, 2024 | Director | 31,751 | $52.40 | Sell | $1,663,752.40 | |
Sept. 10, 2024 | Director | 17,501 | $49.65 | Sell | $868,924.65 | |
Sept. 9, 2024 | Insider | 4,099 | $50.03 | Sell | $205,072.97 | |
Aug. 26, 2024 | Insider | 3,200 | $50.01 | Sell | $160,032.00 | |
Aug. 26, 2024 | Director | 4,300 | $50.01 | Sell | $215,043.00 | |
Aug. 9, 2024 | Insider | 49,006 | $45.15 | Sell | $2,212,620.90 | |
July 29, 2024 | Insider | 1,395 | $49.06 | Sell | $68,438.70 | |
July 16, 2024 | Insider | 10,468 | $53.00 | Sell | $554,804.00 | |
July 12, 2024 | Insider | 5,313 | $50.01 | Sell | $265,703.13 | |
May 9, 2024 | Insider | 3,984 | $38.47 | Sell | $153,264.48 | |
April 2, 2024 | CAO | 368 | $41.76 | Sell | $15,367.68 | |
March 21, 2024 | Insider | 18,235 | $40.34 | Sell | $735,599.90 | |
March 19, 2024 | EVP | 16,000 | $39.22 | Sell | $627,520.00 | |
March 19, 2024 | CEO | 45,494 | $39.22 | Sell | $1,784,274.68 | |
March 19, 2024 | CFO | 15,515 | $39.22 | Sell | $608,498.30 | |
Feb. 14, 2024 | Insider | 1,089 | $50.01 | Sell | $54,460.89 | |
Feb. 12, 2024 | CFO | 1,209 | $51.38 | Sell | $62,118.42 | |
Feb. 12, 2024 | Insider | 791 | $51.38 | Sell | $40,641.58 | |
Feb. 12, 2024 | EVP | 1,594 | $51.38 | Sell | $81,899.72 | |
Feb. 9, 2024 | Insider | 71,774 | $50.38 | Sell | $3,615,974.12 | |
Dec. 27, 2023 | Insider | 5,015 | $50.01 | Sell | $250,800.15 | |
Dec. 5, 2023 | CFO | 7,026 | $35.06 | Sell | $246,331.56 | |
Nov. 24, 2023 | CFO | 10,974 | $35.02 | Sell | $384,309.48 | |
Nov. 8, 2023 | EVP | 5,712 | $28.90 | Sell | $165,076.80 | |
Nov. 3, 2023 | EVP | 80 | $28.00 | Sell | $2,240.00 | |
Sept. 5, 2023 | EVP | 6,166 | $28.05 | Sell | $172,956.30 | |
Aug. 9, 2023 | EVP | 1,718 | $24.66 | Sell | $42,365.88 | |
Aug. 7, 2023 | EVP | 11,223 | $24.18 | Sell | $271,372.14 | |
July 26, 2023 | Insider | 930 | $17.64 | Sell | $16,405.20 | |
March 29, 2023 | CAO | 912 | $17.50 | Sell | $15,960.00 | |
Feb. 14, 2023 | Insider | 554 | $26.87 | Sell | $14,885.98 | |
Feb. 14, 2023 | EVP | 635 | $26.87 | Sell | $17,062.45 | |
Feb. 14, 2023 | CFO | 702 | $26.87 | Sell | $18,862.74 | |
Feb. 9, 2023 | CFO | 1,398 | $27.66 | Sell | $38,668.68 | |
Feb. 9, 2023 | EVP | 1,192 | $27.66 | Sell | $32,970.72 | |
Feb. 9, 2023 | Insider | 834 | $27.66 | Sell | $23,068.44 | |
Feb. 9, 2023 | CAO | 959 | $27.66 | Sell | $26,525.94 | |
Aug. 19, 2022 | Insider | 13,493 | $24.83 | Sell | $335,031.19 | |
July 27, 2022 | Insider | 901 | $11.68 | Sell | $10,523.68 | |
July 1, 2022 | CFO | 7,547 | $4.08 | Sell | $30,791.76 | |
March 29, 2022 | CAO | 1,023 | $11.13 | Sell | $11,385.99 | |
Feb. 15, 2022 | CFO | 833 | $6.10 | Sell | $5,081.30 | |
Feb. 15, 2022 | EVP | 934 | $6.10 | Sell | $5,697.40 | |
Feb. 15, 2022 | Insider | 557 | $6.10 | Sell | $3,397.70 | |
March 30, 2021 | CEO | 10,000 | $20.17 | Buy | $201,700.00 | |
Dec. 2, 2020 | Major Shareholder | 30,939 | $32.39 | Sell | $1,002,114.21 | |
Aug. 31, 2020 | Insider | 25,000 | $30.00 | Sell | $750,000.00 | |
July 1, 2020 | Major Shareholder | 25,527 | $21.87 | Sell | $558,275.49 | |
June 29, 2020 | Major Shareholder | 52,049 | $22.19 | Sell | $1,154,967.31 | |
June 26, 2020 | Director | 300 | $25.04 | Sell | $7,512.00 |
Insiders are both buying and selling Rhythm Pharmaceuticals Inc stock.
The insider traders at Rhythm Pharmaceuticals Inc are: Todd Foley, Joseph Shulman, Keith Michael Gottesdiener, Hunter C Smith, Pamela J Cramer, Jennifer Kayden Lee, Der Ploeg Leonardus H.T. Van, Ra Capital Management, L.P., Yann Mazabraud, David P Meeker, William T Roberts, Nithya Desikan, Jennifer Chien, Lynn A Tetrault, S.A. Ipsen, Christopher Paul German, Bros. Advisors Lp Baker, Jennifer L Good, Orbimed Advisors Llc, and James E Flynn
The most active insider trader at Rhythm Pharmaceuticals Inc is Todd Foley with 24 trades.
Todd Foley has sold the most Rhythm Pharmaceuticals Inc stock with a total value of $16,758,186.66.
Bros. Advisors Lp Baker has bought the most Rhythm Pharmaceuticals Inc stock with a total value of $30,090,000.00.
The most recent insider trade for Rhythm Pharmaceuticals Inc was on Sept. 17, 2024.
The single biggest insider buy for Rhythm Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $15,045,000.00 on Oct. 5, 2017.
The single biggest insider sell for Rhythm Pharmaceuticals Inc was from Orbimed Advisors Llc with a total value of $4,064,919.68 on May 21, 2018.